Institutional members access full text with Ovid®

Share this article on:

Primary bilateral macronodular adrenal hyperplasia

De Venanzi, Agostinoa; Alencar, Guilherme Asmarb; Bourdeau, Isabellea; Fragoso, Maria Candida Barisson Villaresb; Lacroix, Andréa

Current Opinion in Endocrinology, Diabetes & Obesity: June 2014 - Volume 21 - Issue 3 - p 177–184
doi: 10.1097/MED.0000000000000061
ADRENAL CORTEX AND MEDULLA: Edited by Anand Vaidya

Purpose of review: Primary bilateral macronodular adrenal hyperplasia is a rare cause of Cushing's syndrome and is more often diagnosed as bilateral adrenal incidentalomas with subclinical cortisol production. We summarize the recent insights concerning its epidemiology, diagnosis, genetics, pathophysiology, and therapeutic options.

Recent findings: Recent publications have modified our notions on the genetics and pathophysiology of bilateral macronodular adrenal hyperplasia. Combined germline and somatic mutations of armadillo repeat containing 5 gene were identified in familial cases, in approximately 50% of apparently sporadic cases and in the relatives of index cases; genetic testing should allow early diagnosis in the near future. The recent finding of ectopic adrenocortical production of adrenocorticotropic hormone in clusters of bilateral macronodular adrenal hyperplasia tissues and its regulation by aberrant hormone receptors opens new horizons for eventual medical therapy using melanocortin-2 receptor and G-protein-coupled receptor antagonists. Finally, some medical and surgical treatments have been updated.

Summary: Recent findings indicate that bilateral macronodular adrenal hyperplasia is more frequently genetically determined than previously believed. Considering the role of paracrine adrenocorticotropic hormone production on cortisol secretion, the previous nomenclature of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia appears inappropriate, and this disease should now be named primary bilateral macronodular adrenal hyperplasia.

aDivision of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Université de Montréal, Montreal, Quebec H2W 1T8, Canada

bUnidade de Suprarrenal, Disciplina de Endocrinologia e Metabologia, Laboratório de Hormônios e Genética Molecular LIM42, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil

Correspondence to André Lacroix, MD, Professor of Medicine, Division of Endocrinology, Centre hospitalier de l’Université de Montréal-Hôtel-Dieu, 3840 rue Saint-Urbain, Montreal, QC H2W 1T8, Canada. Tel: +1 514 890 8000 x14069; fax: +1 514 412 7208; e-mail: andre.lacroix@umontreal.ca

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins